Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
Similar funds
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.